Identification of novel cancer-specific antigens and application for cellular imunotherapy of hematological malignancies
Identification of novel cancer-specific antigens and application for cellular imunotherapy of hematological malignancies
批准号:
13470206
负责人:
YASUKAWA Masaki
金额:
$8.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To identify the novel cancer-associated antigens and to develop the novel immunotherapy for hematological malignancies, this study was performed. The data obtained from the series of experiments are as follows.1) A WT1-specific, HLA-A24-restricted CTL clone (designated TAK-1) exhibited cytotoxicity against lung cancer cell lines bearing HLA-A24 but did not lyse cells lacking this HLA. Adoptive transfer of TAK-1 into nude mice that had been engrafted with an HLA-A24-positive lung cancer cell line resulted in inhibition of the cancer cell growth and prolonged survival. These findings strongly suggest that WT1 is a universal tumor-associated antigen and that WT1 -targeting immunotherapy offers a potentially effective treatment option for lung cancer as well as leukemia.2) A novel WT1-derived peptide-specific CD8^+ CTL line, designated NIM-1 was established. NIM-1 lysed HLA-A24-positive leukaemia cells, but not HLA-A24 negative leukaemia cells or normal cells.3) Immature dendritic cells (D … More Cs) were loaded with leukemia cells with t(6 ; 9) or t(9 ; 22) and then cocultured with the dek-can fusion peptide-specific or the bcr-abl fusion peptide-specific CD4^+ T-lymphocyte clone. The dek-can peptide-specific and bcr-abl peptide-specific CD4^+ T-lymphocyte clones produced interferon-γ(IFN-γ) when they were cocultured with HLA-DR-matched but not with mismatched DCs which had been loaded with apoptotic as well as necrotic leukemia cells with t(6 ; 9) and t(9 ; 22), respectively. These data indicate that the acute myelogenous leukemia-associated fusion protein, dek-can, and chronic myelogenous leukemia-associated fusion protein, bcr-abl, are both processed and presented by DCs to the fusion peptide-specific CD4^+ T lymphocytes.4) In order to clarify the roles of perforin in antigen-specific cytotoxicity mediated by human CD4^+ CTLs, antigen-specific human CD4^+ T-lymphocyte clones were established from a patient with hereditary perforin deficiency and their cytotoxic activities were investigated. The data demonstrated that perforin-negative CD4^+ CTLs can exert cytotoxicity against Fas-sensitive target cells ; however, perforin plays essential roles in antigen-specific cytotoxicity mediated by human CD4^+ as well as CD8^+ CTLs. Less
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Azuma, T., et al.: "Identification of a novel WT1-derived peptide which induces HLA-A24-restricted anti-leukaemia cytotoxic T lymphocytes"British Journal of Haematology. 116. 601-603 (2002)
Azuma,T.,等人:“诱导 HLA-A24 限制性抗白血病细胞毒性 T 淋巴细胞的新型 WT1 衍生肽的鉴定”英国血液学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Arai, J., et al.: "Identification of human telomerase reverse transcriptase-derived peptides which induce HLA-A24-restiricted antileukemia CTLs"Blood. 97. 2903-2907 (2001)
Arai, J. 等人:“诱导 HLA-A24 限制性抗白血病 CTL 的人端粒酶逆转录酶衍生肽的鉴定”血液。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kakimoto, M., Hasegawa, A., Fujita, S. and Yasukawa, M.: "Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection"J.Virol.. 76. 10338-10345 (2002)
Kakimoto, M.、Hasekawa, A.、Fujita, S. 和 Yasukawa, M.:“人疱疹病毒 6 感染诱导的树突状细胞的表型和功能改变”J.Virol.. 76. 10338-10345 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hasegawa, A., et al.: "Transcriptional down-regulation of CXCR4 induced by impaired association of YY1 with c-Myc in HHV-6-infected cells"Journal of Immunology. 166. 1125-1131 (2001)
Hasekawa, A. 等人:“HHV-6 感染细胞中 YY1 与 c-Myc 的关联受损导致 CXCR4 转录下调”《免疫学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Makita, M., Yasukawa, M.et al.: "Antilung cancer effect of WT1-specific cytotoxic T lymphocytes"Clinical Cancer Research. 8. 2626-2613 (2002)
Makita, M., Yasukawa, M.等人:“WT1特异性细胞毒性T淋巴细胞的抗肺癌作用”临床癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Development of the novel gene-immunotherapy using artificial CTL targeting leukemia stem cells
-
批准号:24390245
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2012
-
负责人:YASUKAWA Masaki
-
依托单位:
Development of a novel cancer therapy using soluble T-cell receptor
-
批准号:23659489
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2011
-
负责人:YASUKAWA Masaki
-
依托单位:
Development of cancer immunotherapy using co-transfer of cancer-specific TCR gene and chemokine receptor gene
-
批准号:21390294
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2009
-
负责人:YASUKAWA Masaki
-
依托单位:
Novel hematopoietic stem cell transplantation using cancer-specific T-cell receptor gene transfer
-
批准号:19390265
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2007
-
负责人:YASUKAWA Masaki
-
依托单位:
Development of novel immunogene therapy for hamatopietic malignancies
-
批准号:17390278
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.34万
-
财政年份:2005
-
负责人:YASUKAWA Masaki
-
依托单位:
Novel immunogene therapy for hematopoietic malignancies
-
批准号:15390301
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:2003
-
负责人:YASUKAWA Masaki
-
依托单位:
Development of novel immunogene therapy for hematological malignancies
-
批准号:12557081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.68万
-
财政年份:2000
-
负责人:YASUKAWA Masaki
-
依托单位:
Immunogene therapy of cancer and virus infections using immortalized T-cell clones
-
批准号:11670449
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:YASUKAWA Masaki
-
依托单位:
Molecular analysis of new herpesvirusinfections
-
批准号:09670477
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:YASUKAWA Masaki
-
依托单位:
Abnormality of signal Transduction via T-cell receptors mediated by retrovirus infection
-
批准号:02670283
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1990
-
负责人:YASUKAWA Masaki
-
依托单位:
海外基金